MyAverix Finance
SW · Healthcare
Molecular Partners AG (MOLN)
Biotechnology
Molecular Partners AG (MOLN) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MOLN
Molecular Partners AG (MOLN) — FAQ
What is MOLN's P/E ratio?
The price-to-earnings (P/E) ratio for Molecular Partners AG (MOLN) is 25.00 (data as of 2026-05-24).
Does Molecular Partners AG pay a dividend?
Dividend yield is not available in the current snapshot for Molecular Partners AG (MOLN). Check the MyAverix Finance app for the latest dividend data.
What sector is Molecular Partners AG in?
Molecular Partners AG (MOLN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MOLN listed on?
MOLN is listed on SW.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.